Absci Corp

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.93

-0.78 (-7.28%)

As of Sep 23, 2:50 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +137.2% upside

Low Target $16.79

Average Target $23.55

High Target $35.63

Current Price $9.93

Current
$9.93

Target
$23.55

$16.79 $23.55 avg $35.63

Scenario Analysis

Bear Case

$16.79

69.1%

Low target

Base Case

$23.55

+137.2%

Avg target

Bull Case

$35.63

+258.8%

High target

Risk/Reward

3.7x

Highly favorable

Price in Context

52-Week High

$12.06

-17.6% from high

52-Week Low

$2.24

+343.3% from low

Target vs 52W High

$23.55

+95.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%